prenat
influenza
exposur
increas
risk
schizophrenia
bring
question
respiratori
virus
may
contribut
neuropsychiatr
diseas
etiopatholog
human
coronavirus
caus
respiratori
infect
rang
serious
common
cold
sever
acut
respiratori
syndrom
like
influenza
coronavirus
neurotrop
test
associ
coronavirus
seriou
mental
disord
util
recent
develop
assay
measur
immunoglobulin
g
igg
respons
human
coronaviru
strain
patient
recent
onset
psychot
symptom
nonpsychiatr
control
express
result
quantit
antibodi
level
qualit
seropreval
rel
defin
seroposit
cutoff
valu
patient
igg
level
higher
control
show
highli
signific
patienttocontrol
differ
p
p
coronavirus
seropreval
patient
vs
control
greatest
intergroup
differ
observ
vs
p
associ
patient
group
support
multivari
analys
control
age
gender
race
socioeconom
statu
smoke
statu
odd
ratio
confid
interv
ci
p
ci
p
among
patient
associ
schizophreniaspectrum
ci
p
mood
disord
coronaviru
exposur
may
repres
comorbid
risk
factor
neuropsychiatr
diseas
futur
studi
explor
link
time
coronaviru
infect
subsequ
develop
schizophrenia
disord
psychot
symptom
recent
onset
n
p
e
recent
onset
v
p
mood
disord
v
p
schizophreniaspectrum
disord
v
p
prenat
perinat
infect
associ
onset
adult
psychiatr
ill
suscept
individu
matern
exposur
toxoplasma
gondii
influenza
measl
polio
genit
andor
reproduct
infect
confer
increas
risk
schizophrenia
develop
offspr
childhood
infect
bacteri
viral
mening
may
also
play
role
psychot
diseas
etiolog
connect
adult
infect
schizophrenia
less
clearcut
serolog
collect
includ
sampl
taken
prior
diseas
diagnosi
provid
valuabl
inform
regard
microbi
exposur
time
symptom
onset
adult
popul
prospect
studi
us
militari
cohort
antibodi
gondii
human
herpesviru
significantli
associ
subsequ
develop
schizophrenia
individu
respiratori
virus
influenza
virus
coronavirus
potenti
neurotrop
enter
brain
via
olfactori
neural
pathway
human
coronavirus
caus
infect
rang
common
cold
sever
acut
respiratori
syndrom
sar
coronavirus
singlestrand
rna
virus
outer
envelop
distinct
crownlik
morpholog
nonsar
respiratori
infect
occur
group
group
ii
coronavirus
first
describ
wherea
recent
discov
first
describ
data
clinic
postmortem
vitro
anim
studi
support
coronaviru
exposur
neurolog
consequ
includ
psychiatr
symptom
enceph
clinic
report
psychiatr
symptom
auditori
visual
hallucin
manic
depress
disord
describ
studi
sar
infect
coronaviru
rna
found
human
brain
autopsi
sampl
individu
multipl
sclerosi
sar
virus
known
infect
neuron
associ
neuropsychiatr
effect
sar
antigen
target
current
administ
vaccin
good
candid
studi
role
adult
infect
neuropsychiatr
ill
previous
describ
develop
serolog
assay
specif
immunodomin
nucleocapsid
protein
nonsar
human
coronaviru
felin
coronaviru
known
caus
infect
human
also
previous
describ
uniqu
studi
popul
compos
group
patient
experienc
recent
onset
psychot
symptom
subsequ
diagnos
specif
neuropsychiatr
diseas
compar
coronaviru
immunoglobulin
g
igg
antibodi
level
group
healthi
nonpsychiatr
adult
determin
extent
coronaviru
exposur
may
correl
recent
onset
seriou
mental
ill
recruit
individu
recent
onset
psychot
symptom
screen
consecut
admiss
inpati
day
hospit
program
sheppard
pratt
health
system
larg
notforprofit
psychiatr
center
baltimor
md
detail
screen
popul
previous
describ
inclus
criteria
onset
psychot
symptom
first
time
within
past
month
defin
presenc
posit
psychot
symptom
least
moder
sever
last
day
sever
day
occur
sever
time
week
age
year
inclus
voluntari
admiss
either
inpati
day
hospit
program
exclus
criteria
mental
retard
psychot
symptom
occur
context
substanc
abus
intox
withdraw
histori
intraven
drug
use
gener
medic
condit
human
immunodefici
viru
hiv
seizur
disord
might
affect
cognit
statu
half
individu
recent
onset
psychot
symptom
diagnos
mood
disord
n
half
schizophrenia
psychot
disord
n
base
criteria
defin
diagnost
statist
manual
mental
disord
fourth
edit
text
revis
dsmiv
tr
axi
disord
specif
diagnos
dsmivtr
code
sampl
size
list
tabl
total
individu
without
histori
psychiatr
disord
recruit
post
announc
screen
rule
current
past
psychiatr
disord
structur
clinic
interview
dsmiv
axi
disord
particip
age
year
inclus
none
follow
current
substanc
abus
past
month
histori
intraven
substanc
abus
mental
retard
medic
disord
would
affect
cognit
perform
epilepsi
histori
enceph
head
trauma
report
neurolog
disord
central
nervou
system
clinic
appar
herpesviru
infect
recent
treatment
antivir
medic
basic
demograph
data
studi
popul
shown
tabl
diagnost
group
differ
significantli
age
gender
matern
educ
level
smoke
statu
variabl
includ
multivari
analys
describ
blood
sampl
obtain
venipunctur
sera
separ
assess
antibodi
coronaviru
antigen
assay
describ
studi
approv
institut
review
board
sheppard
pratt
health
system
john
hopkin
medic
institut
follow
establish
guidelin
investig
carri
accord
latest
version
declar
helsinki
particip
provid
written
inform
consent
studi
procedur
explain
develop
applic
coronaviru
assay
previous
describ
brief
recombin
glutathion
stransferas
gst
fusion
nucleocapsid
protein
human
coronavirus
felin
coronaviru
gener
via
baculoviru
clone
protein
express
trichoplusia
ni
high
five
insect
cell
orbigen
san
diego
ca
coronaviru
reactiv
measur
mean
enzymelink
immunosorb
assay
sera
studi
particip
dilut
incub
nucleocapsid
antigen
bound
solid
phase
use
modifi
gstcaptur
method
neg
control
antigen
includ
prepar
contain
baculoviru
dna
insect
cell
gst
clone
vector
without
nucleocapsid
insert
express
result
quantit
antibodi
level
qualit
seropreval
rel
defin
seroposit
cutoff
valu
minim
error
associ
platetopl
variat
data
mean
normal
mean
normal
done
adjust
absorb
individu
mean
optic
densiti
valu
nonpsychiatr
control
plate
equal
valu
signific
differ
group
quantit
mean
antibodi
level
analyz
test
signific
differ
qualit
rate
seroposit
group
identifi
v
test
level
qualit
aspect
gener
new
seroposit
cutoff
valu
base
meannorm
data
valu
differ
previous
gener
raw
data
coronaviru
assay
develop
trial
new
seroposit
cutoff
valu
defin
follow
continu
previou
studi
also
analyz
data
base
cutoff
methodolog
use
previous
determin
cutoff
valu
signific
associ
diagnost
group
assess
multinomi
logist
regress
use
diagnost
group
princip
outcom
variabl
quantit
antibodi
level
covari
covari
use
regress
age
gender
race
matern
educ
level
smoke
statu
inform
regard
matern
educ
level
use
reflect
socioeconom
statu
avail
individu
recent
onset
psychot
symptom
analys
perform
stata
version
stata
corp
lp
colleg
station
tx
found
recent
onset
psychot
symptom
significantli
associ
coronaviru
exposur
determin
bivari
analys
quantit
antibodi
level
qualit
determin
seropreval
coronavirus
mean
antibodi
level
antigen
significantli
greater
recent
onset
group
n
compar
control
n
p
valu
rang
statist
p
valu
shown
tabl
test
show
signific
differ
patient
control
p
show
highli
signific
intergroup
differ
p
rate
seroposit
recent
onset
popul
significantli
increas
human
coronavirus
compar
control
p
valu
rang
v
statist
p
valu
shown
tabl
greatest
differ
seroposit
rate
patient
control
observ
vs
p
coronaviru
seroposit
antibodi
level
increas
mood
recent
onset
p
mood
disord
p
schizophreniaspectrum
disord
p
c
recent
onset
v
p
schizophreniaspectrum
disord
v
p
schizophreniaspectrum
disord
diagnos
compar
control
coronaviru
measur
gener
consist
elev
schizophreniaspectrum
disord
diagnosi
p
valu
rang
mood
disord
diagnosi
p
valu
rang
tabl
employ
multivari
analys
examin
relationship
diagnosi
antibodi
level
demograph
variabl
multivari
model
includ
age
gender
race
matern
educ
smoke
statu
covari
multivari
analys
confirm
statist
signific
associ
odd
ratio
ci
p
ci
p
antibodi
level
recent
onset
psychot
symptom
diagnosi
or
p
valu
ci
shown
tabl
antibodi
level
significantli
associ
schizophreniaspectrum
disord
compar
control
ci
p
tabl
antibodi
level
show
modest
associ
mood
disord
compar
control
ci
p
tabl
studi
estim
coronaviru
immunoreact
measur
antibodi
level
seropreval
found
increas
rate
immunoreact
certain
coronaviru
strain
individu
recent
onset
psychot
symptom
compar
control
without
histori
psychiatr
disord
coronaviru
strain
test
newli
discov
show
consist
diseaseassoci
signific
statist
analys
confer
risk
neuropsychiatr
diseas
coronaviru
immunoreact
modestli
elev
evid
or
patient
group
broken
mood
schizophreniaspectrum
disord
howev
associ
schizophreniaspectrum
disord
increas
particular
subject
studi
individu
schizophrenia
determin
viral
infect
symptom
onset
tempor
link
assign
patient
schizophreniaspectrum
mood
disord
group
may
introduc
confound
element
smaller
group
analys
schizoaffect
disord
mood
disord
also
possibl
diagnost
uncertainti
present
close
start
ill
psychot
symptom
may
led
misclassif
exampl
differenti
bipolar
disord
psychot
featur
schizoaffect
disord
may
alway
accur
withingroup
distribut
also
may
influenc
studi
outcom
mood
disord
subgroup
n
patient
suffer
major
depress
remaind
subtyp
bipolar
disord
limit
also
consid
interpret
result
present
includ
studi
design
control
group
repres
serum
sampl
antibodi
measur
repres
immunolog
profil
base
singl
time
point
therefor
data
analyz
cross
section
manner
futur
studi
incorpor
prospect
design
allow
assess
chang
antibodi
level
time
enabl
us
ascertain
util
antibodi
measur
diagnost
tool
andor
etiolog
agent
anoth
potenti
limit
factor
may
inclusionexclus
criteria
control
group
led
sampl
may
fulli
repres
person
gener
popul
net
effect
recruit
volunt
exclud
axi
disord
viral
infect
antivir
therapi
may
fact
control
group
unusu
healthi
ideal
control
group
would
compos
individu
nonpsychot
learn
development
disord
live
similar
lifestyl
go
develop
mental
disord
psychot
symptom
respect
exclus
current
viral
infect
antivir
medic
control
patient
group
viru
show
coinfect
coronavirus
could
potenti
bia
result
favor
spuriou
associ
note
perform
similar
evalu
influenza
b
virus
popul
differ
antibodi
level
patient
control
detect
data
shown
thu
provid
evid
intergroup
unequ
exposur
rate
hypothesi
least
respiratori
virus
futur
addit
control
group
evalu
determin
preval
coronaviru
infect
wide
rang
human
popul
start
point
though
use
control
popul
appropri
author
knowledg
coronavirus
never
test
serolog
associ
patient
particular
disord
mental
ill
predispos
individu
high
rate
medic
comorbid
thu
make
difficult
disentangl
gener
poor
health
due
suboptim
live
environ
atrisk
lifestyl
diseas
risk
relat
exposur
specif
pathogen
document
individu
mental
disord
increas
incid
cardiovascular
diseas
diabet
obes
hypertriglyceridemia
hepat
b
viru
hiv
smokingrel
ill
compar
peopl
histori
neuropsychiatr
disord
specul
environment
effect
live
condit
may
less
like
confound
factor
present
studi
cohort
compos
individu
rel
young
recent
becom
symptomat
compar
peopl
suffer
seriou
psychiatr
disord
extend
period
subject
control
group
older
mother
fewer
year
educ
smoke
less
adjust
multivari
analys
factor
age
socioeconom
statu
smoke
nevertheless
epidemiolog
explan
could
account
increas
exposur
rate
observ
patient
group
multipl
environment
factor
like
contribut
comorbid
health
condit
mental
ill
mental
health
polici
effort
would
benefit
data
document
poor
physic
health
individu
seriou
mental
disord
data
divers
clinic
anim
cell
cultur
studi
support
coronavirus
neurotrop
peopl
infect
surviv
sar
seriou
neuropsychiatr
complic
includ
psychosi
observ
auditori
visual
hallucin
well
manic
depress
disord
reportedli
associ
sar
infect
extent
neurolog
problem
sar
patient
origin
viru
rather
medic
use
treat
infect
current
understood
howev
sarsspecif
nucleotid
sequenc
isol
cerebrospin
fluid
postmortem
brain
tissu
suggest
viral
invas
may
play
role
ensu
psychiatr
complic
evid
coronaviru
infect
central
nervou
system
also
come
studi
multipl
sclerosi
diseas
character
nerv
demyelin
revers
transcriptionpolymeras
chain
reaction
postmortem
brain
tissu
confirm
individu
andor
transcript
present
one
report
document
signific
differ
brain
coronaviru
rna
case
control
studi
evalu
extent
recent
discov
coronavirus
invad
neuron
cell
warrant
summari
result
studi
document
coronaviru
exposur
may
comorbid
risk
factor
individu
seriou
mental
disord
investig
need
determin
respiratori
infect
subsequ
neuroinvas
could
explain
associ
increas
coronaviru
seropreval
recent
onset
psychot
symptom
note
cinanserin
serotonin
antagonist
origin
develop
treatment
schizophrenia
recent
shown
abil
inhibit
replic
wide
rang
coronavirus
better
understand
role
coronavirus
etiopathogenesi
disord
psychot
symptom
might
lead
new
method
studi
diagnos
treat
diseas
stanley
medic
research
institut
